3Ljosaa TM, Mork C, Stubhaug A, et al. Skin pain and skin discomfort is associated with quality of life in patients with psoriasis [J]. J Eur Acad Dermatol Venereal, 2012, 26(1):29-35.
4Nograles KE, Zaba LC, Guttman-Yassky E, et al. Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways [J]. Br J Dermatol, 2008, 159 (5): 1092-1102.
5Ren V, Dao H Jr. Potential role of ixekizumab in the treatment of moderate-to-severe plaque psoriasis [J]. Clin Cosmet Investig Dermatol, 2013, 6: 75-80.
6Goodman WA, Levine AD, Massari JV, et al. IL-6 signaling in psoriasis prevents immune suppression by regulatory T cells [J]. J Immunol, 2009, 183 (5): 3170-3176.
7Arican O, Aral M, Sasmaz S, et al. Serum levels of TNF- alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity [J]. Mediators Inflamm, 2005, 2005 (5): 273-279.
8Coimbra S, Oliveira H, Reis F, et al. Interleukin (IL)-22, IL-17, IL-23, IL-8, vascular endothelial growth factor and tumour necrosis factor-α levels in patients with psoriasis before, during and after psoralen-ultraviolet A and narrowband ultraviolet B therapy [J]. Br J Dermatol, 2010, 163(6): 1282-1290.
9Debra A. Hoppensteadt,Jawed Fareed,Phillip Raake,Wolfram Raake.??Endogenous Release of Tissue Factor Pathway Inhibitor by Topical Application of an Ointment Containing Mucopolysaccharide Polysulfate to Nonhuman Primates(J)Thrombosis Research . 2001 (2)
10Tadao Kumokawa,Kazumasa Hirata,Keiichi Sato,Satoshi Kano.??Dermal absorption of mucopolysaccharide polysulfate (heparinoid) in human and minipig(J)Arzneimittelforschung . 2011 (02)
